Boysen, Anders Toftegaard http://orcid.org/0000-0002-0192-1413
Whitehead, Bradley
Revenfeld, Anne Louise S.
Gupta, Dhanu
Petersen, Thor
Nejsum, Peter
Funding for this research was provided by:
Jascha Fonden (2022-0357)
Riisfort Fonden (25/2 2022)
Sundhedsvidenskabelige Fakultet, Aarhus Universitet (Funded PhD scholarship)
Carlsbergfondet (CF21-0315)
Danmarks Frie Forskningsfond (DFF-1032-00242B)
Article History
Received: 1 July 2024
Accepted: 26 August 2024
First Online: 11 September 2024
Declarations
:
: Written informed consent was obtained from all the participants before inclusion. The study was conducted under the ethically approved project: Cellebaseret behandling af patienter med multipel sklerose. Approval was granted by The South Denmark Region Committee on Biomedical Research Ethics and the Danish Data Protection Agency (no. 23/55327). The project number is S-20220041 and has an amendment with the number 106489. Ethics approval was granted on the 5. August 2022 and the amendment was approved 5. December 2023.
: No individual information that could identify the donors was gathered.
: The authors declare that they have no competing interests.